Compare Novartis with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs DR. DATSONS LABS - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS DR. DATSONS LABS NOVARTIS/
DR. DATSONS LABS
 
P/E (TTM) x 479.2 -10.9 - View Chart
P/BV x 27.8 0.2 17,120.1% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 NOVARTIS   DR. DATSONS LABS
EQUITY SHARE DATA
    NOVARTIS
Mar-18
DR. DATSONS LABS
Mar-14
NOVARTIS/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs758126 603.5%   
Low Rs57931 1,873.8%   
Sales per share (Unadj.) Rs228.4133.0 171.7%  
Earnings per share (Unadj.) Rs31.70.2 20,933.6%  
Cash flow per share (Unadj.) Rs32.86.6 495.8%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs297.1128.8 230.7%  
Shares outstanding (eoy) m24.6931.66 78.0%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x2.90.6 497.5%   
Avg P/E ratio x21.1516.1 4.1%  
P/CF ratio (eoy) x20.411.8 172.3%  
Price / Book Value ratio x2.20.6 370.3%  
Dividend payout %31.50-   
Avg Mkt Cap Rs m16,5052,477 666.2%   
No. of employees `0000.7NA-   
Total wages/salary Rs m1,44556 2,580.9%   
Avg. sales/employee Rs Th8,441.3NM-  
Avg. wages/employee Rs Th2,163.6NM-  
Avg. net profit/employee Rs Th1,173.1NM-  
INCOME DATA
Net Sales Rs m5,6394,211 133.9%  
Other income Rs m1,71879 2,183.4%   
Total revenues Rs m7,3574,289 171.5%   
Gross profit Rs m-63569 -11.0%  
Depreciation Rs m25204 12.4%   
Interest Rs m55430 12.9%   
Profit before tax Rs m1,57513 12,403.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7926 12,977.0%   
Profit after tax Rs m7845 16,325.0%  
Gross profit margin %-1.113.5 -8.2%  
Effective tax rate %50.348.0 104.6%   
Net profit margin %13.90.1 12,189.9%  
BALANCE SHEET DATA
Current assets Rs m9,5226,852 139.0%   
Current liabilities Rs m3,2966,711 49.1%   
Net working cap to sales %110.43.3 3,296.9%  
Current ratio x2.91.0 282.9%  
Inventory Days Days37161 22.8%  
Debtors Days Days28318 8.9%  
Net fixed assets Rs m463,673 1.3%   
Share capital Rs m123317 39.0%   
"Free" reserves Rs m7,2133,761 191.8%   
Net worth Rs m7,3364,078 179.9%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m11,10512,633 87.9%  
Interest coverage x29.51.0 2,863.9%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.3 152.3%   
Return on assets %7.63.4 219.4%  
Return on equity %10.70.1 9,073.3%  
Return on capital %22.27.7 289.6%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m61964 6.3%   
Fx outflow Rs m3,630607 598.0%   
Net fx Rs m-3,570357 -1,000.2%   
CASH FLOW
From Operations Rs m1,6101,345 119.7%  
From Investments Rs m687-2,256 -30.5%  
From Financial Activity Rs m-2,677-1,200 223.1%  
Net Cashflow Rs m-380-2,111 18.0%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 0.0 -  
FIIs % 1.6 1.4 118.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 94.1 22.8%  
Shareholders   41,647 20,807 200.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare NOVARTIS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 14, 2019 01:15 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS